Register for OBR daily


KH_ASCO_Webinar_300x250

To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

GALE $2.29 0.2100 +10.10%
EPZM $23.35 1.6900 +7.80%
SPPI $7.18 0.2800 +4.06%
BDSI $8.66 0.1900 +2.24%
NYMX $5.24 0.0900 +1.75%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

PARD $0.21 -0.1099 -34.34%
IMNP $3.96 -0.5300 -11.80%
TGTX $5.16 -0.6600 -11.34%
IMMU $4.15 -0.4200 -9.19%
GERN $2.00 -0.1900 -8.68%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | Next > | Last >>

News Digest – When Muscle Turns to Bone, Prostate Cancer Tests, ‘Zombie’ Cancer Cells and More

(Cancer Research UK/Science Blog) Apr 12, 2014 - Our researchers uncovered a remarkable genetic link between a rare condition that turns muscle into bone and a deadly form of childhood brain tumour called DIPG. We covered the research in this blog post.
read article 



Experimental Drug Shows Promise for Treatment-Resistant Leukemias

(Johns Hopkins Medicine) Apr 8, 2014 - Research in mice and human cell lines has identified an experimental compound dubbed TTT-3002 as potentially one of the most potent drugs available to block genetic mutations in cancer cells blamed for some forms of treatment-resistant leukemia.
read press release 



OncoBriefs: Notable Studies from AACR

(MedPage Today) Apr 13, 2014 - Irregular menstrual cycles predicted an increased risk of ovarian cancer and dying of the disease, according to a study reported here.
read article (free registration required) 



Ocular Effects Common After Childhood Bone Marrow Transplant

(Medscape Medical News) Apr 11, 2014 - Ocular complications, particularly cataract and dry eye syndrome, are common in survivors of childhood bone marrow transplantation, and the monitoring of such patients should include careful ocular screening, according to a new study.
read article (free registration required) 



A Quarter of Men Drop Out of Prostate Cancer Monitoring, Casting Doubt on Safety of “Active Surveillance”

(EAU) Apr 12, 2014 - A long-term follow up of prostate cancer patients shows that the option of monitoring slow-growing prostate cancer may not be as safe as thought, due to a quarter of men dropping out of the monitoring programme.
read press release 



Blood Type Influences Prostate Cancer Relapse, Study Shows

(The Telegraph [UK]) Apr 14, 2014 - A man's blood group has been shown to significantly influence the chance that prostate cancer will return after successful surgery.
read article 



Gene Linked to Pediatric Kidney Cancer Suggests New Strategies for Kidney Regeneration

(Science Codex) Apr 13, 2014 - Nearly one-third of cases of Wilms tumor, a pediatric cancer of the kidney, are linked to a gene called Lin28, according to research from Boston Children's Hospital.
read article 



Chemotherapy Before or After Surgery for High-Risk Bladder Cancer Improves Survival, But is Not Routinely Administered

(Wiley) Apr 14, 2014 - Contrary to treatment guidelines for high-risk bladder cancer, chemotherapy before or after surgery is not commonly used in routine clinical practice.
read press release 



New Advances in Hepatocellular Carcinoma Diagnosis, Staging and Treatment All Predicted to Improve Patient Outcomes

(EASL) Apr 12, 2014 - Epidemiological, genetic and clinical data presented today at the International Liver Congress(TM) 2014 are collectively focussed on different approaches designed to improve the diagnosis, staging and treatment of hepatocellular carcinoma (HCC).
read press release 



How Morcellators Simplified the Hysterectomy but Posed a Hidden Cancer Risk

(Wall Street Journal) Apr 11, 2014 - The morcellator, a tool that simplifies hysterectomies, faces backlash as evidence mounts that most doctors haven't informed patients that it may spread a rare cancer.
read article (paid subscription required) 



A New Cancer Drug On The Horizon

(FoxNews.com/Staring Down Cancer) Apr 10, 2014 - A few weeks ago, I mentioned that there would be an exciting announcement made this week at the American Association of Cancer Research (AACR) annual meeting held this year in San Diego.
read article 



FDA Approves Lipiodol (Ethiodized Oil) Injection for Imaging of Tumors in Adults with Known Hepatocellular Carcinoma (HCC)

(Yahoo! Finance) Apr 10, 2014 - Guerbet announced that Lipiodol was approved by the FDA for selective hepatic intra-arterial use for imaging tumors in adults with known hepatocellular carcinoma (HCC).
read article 



Op-Ed: The Tobacco Ties That Bind by Peter B. Bach

(New York Times) Apr 10, 2014 - Why doesn’t the cancer society protest all cigarette sales?
read article 



After Skin Cancer, Removable Model Replaces Real Ear

(U.S. News & World Report/HealthDay News) Apr 11, 2014 - During his 10-year struggle with basal cell carcinoma, Henry Fiorentini emerged minus his right ear, and minus the hearing that goes with it.
read article 



Update on the 2013 ASH Initiative – Choosing Wisely

(ASH/The Hematologist) Apr 10, 2014 - Choosing Wisely is an initiative led by the ABIM Foundation in partnership with professional societies across the country.
read article 



Medicare Considers Using NCCN Guides as Clinical Pathways

(Medscape Medical News) Apr 10, 2014 - The Centers for Medicare and Medicaid Services (CMS) are reviewing a proposal from a major consulting company to use oncology clinical pathways in a pilot program designed to control costs and promote more uniform medical practice, according to a report published in a trade publication.
read article (free registration required) 



Tumor-Suppressor Connects With Histone Protein to Hinder Gene Expression

(MD Anderson) Apr 10, 2014 - ZMYND11 “reads” methylated variant to thwart cancer; tied to breast cancer patient survival.
read press release 



Immunotherapy Could Help Tackle Tough Liver Cancers

(EASL) Apr 11, 2014 - Significant new data presented today at the International Liver Congress™ 2014 indicate that liver cancer (Hepatocellular Carcinoma (HCC)) may be treated by adoptive T-cell therapy.
read press release 



Dendreon Says Prelim. Data from LT Phase II STAND Study Will Be Presented at EAU Congress, Will Show Immune Responses with PROVENGE Enhanced, Sustained

(Morningstar/Benzinga) Apr 11, 2014 - Dendreon Corporation today announced the presentation of preliminary data from a long-term analysis of the Phase II STAND study demonstrating that tumor-specific T-cell responses appear to be enhanced and sustained when PROVENGE (sipuleucel-T) is given after androgen deprivation therapy (ADT) in patients with biochemically-recurrent prostate cancer (BRPC) at high risk for metastases.
read article 



Oncology Societies Warn of Distortion in Medicare Data Dump

(Medscape Medical News) Apr 11, 2014 - Anger at the unprecedented release of Medicare data for individual doctors earlier this week is palpable in all the statements that have been issued in response by the leading oncology societies.
read article (free registration required) 



Pfizer’s Ian Read Becomes PhRMA Board Chairman; Ken Frazier, George Scangos Assume New Posts

(PhRMA) Apr 11, 2014 - Ian C. Read, chairman and CEO of Pfizer, Inc, was elected chairman of the Pharmaceutical Research and Manufacturers of America (PhRMA) today at the trade association’s annual meeting.
read press release 



Creating Body Parts in a Lab: 'Things Are Happening Now'

(CNN) Apr 10, 2014 - Two body parts. One scientific leap.
read article 



Doctors Welcome Hepatitis C Drug Rivals, Gilead Still Leads

(Reuters) Apr 11, 2014 - Doctors at a key medical conference welcomed the prospect of more new drugs to treat the liver-destroying hepatitis C virus, while agreeing that Gilead Sciences Inc continues to lead the effort.
read article 



PhRMA: Sunshine Not Driving Docs Indoors

(Medpage Today) Apr 10, 2014 - Doctors haven't disengaged from drug companies in the months since the tracking of financial relationships between them started, several pharmaceutical executives here said.
read article (free registration required) 



These Maps Tell You Everything That’s Wrong With Our Drug Pricing System

(Washington Post/Wonkblog) Apr 11 2014 - The way that doctors across the U.S. treat a chronic eye disease tells a lot about Medicare pricing.
read article (free registration required)